Both in Pharmaceuticals
Phibro Animal Health vs ANI Pharmaceuticals
Over the past year PAHC returned −10.4% and ANIP returned −23.5%; their daily moves had a correlation of 0.24.
PAHC −10.4% ANIP −23.5%Growth of $1, one year, split-adjusted
| Metric | PAHC | ANIP |
|---|---|---|
| Price | $38.88 | $72.00 |
| Market cap | $1.58B | $1.65B |
| Today | +0.05% | −1.59% |
| 1 month | +8.4% | −1.3% |
| 6 months | −29.2% | −10.4% |
| Year to date | +4.1% | −8.8% |
| 1 year | −5.6% | −21.9% |
| Revenue growth (YoY) | +4.8% | +25.9% |
| Gross margin | 33.9% | 62.4% |
| Net margin | 5.5% | 8.6% |
| P/E (TTM) | 15.8× | 16.6× |
| Price / sales | 1.0× | 1.7× |
| Net cash | -$650.8M | -$234.7M |
| Dividend yield | 1.23% | — |
| Volatility (60d) | 30.4% | 29.0% |
| Short % of float | 4.9% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).